Michael Garkavij, Mattias Nickel, Katarina Sjögreen-Gleisner, Michael Ljungberg, Tomas Ohlsson, Karin Wingårdh, Sven-Erik Strand and Jan Tennvall 177Lu-[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy Cancer 116
Three different methods were used to evaluate the absorbed dose to the kidneys in patients with disseminated neuroendocrine tumors treated with 177Lu-(DOTA0,Tyr3) octreotate. Dosimetry based on planar images generally gave higher absorbed dose values compared with methods including single-photon emission computed tomography (SPECT) data. Two different SPECT-based methods gave similar values, although the calculations were based on different assumptions.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf